Yuyu Pharma, Inc.
Yuyu Pharma, Inc. (KRX: 000225) is trading at ₩3,605.00, about ₹260 at today's KRW/INR rate, as of 8 Oct 2026, 2:30 AM ET, down 0.55% today. Yuyu Pharma is not currently available to trade on Paasa; this page shows its price, statistics and the Indian tax treatment for information.
Quote
Today's low
₩3,580.00
Today's high
₩3,685.00
52 week low
₩3,345.00
52 week high
₩5,700.00
000225 opened at ₩3,600.00, closed previously at ₩3,625.00, and has traded between ₩3,345.00 and ₩5,700.00 over the past 52 weeks.
About
Yuyu Pharma, Inc. is dedicated to the development and commercialization of a wide spectrum of pharmaceutical products. Its comprehensive collection of prescription medications spans numerous therapeutic categories, offering treatments for conditions such as osteoporosis, disorders affecting brain and bone metabolism (including hypocalcemia), central and peripheral circulatory impairments, thromboembolism, respiratory issues, high blood pressure, pulmonary tuberculosis, arthritis, diabetic neuropathy, and eczematous dermatitis. The company further supplies other cardiovascular agents, antibiotics, and skeletal muscle relaxants. Beyond its prescription offerings, Yuyu Pharma also produces over-the-counter drugs and various health supplements. Originally established in 1941 as YuYu Inc., the company adopted its current name, Yuyu Pharma, Inc., in May 2008, and its corporate headquarters are located in Seoul, South Korea.
Key statistics
Avg. volume
33.17K
Market cap
₩54.33B
P/E Ratio
5.14
Price-to-sales ratio
0.42
Enterprise value
₩73.74B
Free cash flow yield
10.43%
Debt-to-equity ratio
0.21
Return on equity
6.31%
ROIC
6.02%
Beta
0.35
Dividend yield
2.99%
Last dividend
₩125.00
Financial overview
Revenue
₩140.88B
Earnings per share
₩492.00
Free cash flow
₩7.81B
Net profit margin
8.66%
Gross margin
38.17%
EBITDA
₩16.63B
Revenue growth
5.81%
Similar securities
This is not an investment recommendation
Yuyu Pharma for Indian investors
Yuyu Pharma is listed on the Korea Exchange. It is not currently available to trade on Paasa; the figures on this page are for information, and the tax notes below apply to Indian residents who hold it.
Taxes on Yuyu Pharma for Indian residents
Trading and limits
- Trading hours
- 9:00 am – 3:30 pm KST
- LRS limit
- $250,000Per financial year, under the RBI's Liberalised Remittance Scheme.
Tax for Indian residents
- TCS on remittance
- 20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
- Capital gains in India
- 12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
- Dividends
- Slab rateDividends are taxed at your slab rate in India. Yuyu Pharma’s current yield is 2.99%.Dividend tax explained
FAQs
Can I buy Yuyu Pharma on Paasa?
Yuyu Pharma (000225) has been listed on the Korea Exchange since 2005, in the Drug Manufacturers - Specialty & Generic industry. Yuyu Pharma is not currently available to trade on Paasa; the figures on this page are for information. Indian residents who hold it through another broker still declare it under the rules below.
How much does one Yuyu Pharma share cost in rupees?
One Yuyu Pharma share is ₩3,605.00 — about ₹260 at a KRW/INR rate of 0.0722 on 8 Oct 2026. Both the Yuyu Pharma price and the rupee rate move during the day, so the rupee cost changes with them.
What are the LRS and TCS rules for investing abroad from India?
Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability.
How are gains on Yuyu Pharma shares taxed in India?
Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the KRW/INR rate on the purchase and the sale date, so the rupee move counts alongside the Yuyu Pharma price.
Does Yuyu Pharma pay a dividend, and how is it taxed in India?
Yes. Yuyu Pharma pays a dividend and the current yield is 2.99%; the last declared dividend was ₩125.00 per share, about ₹9.02. Dividends are taxed at your slab rate in India.
When does KRX trade, in Indian time?
The Korea Exchange trades 5:30 am – 12:00 pm IST in Indian time.
Do I have to declare Yuyu Pharma shares in my Indian tax return?
Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. The holding is reported with its cost and its closing value.
Does the rupee rate affect what I make on Yuyu Pharma?
Yes. Yuyu Pharma is priced in KRW, so your rupee outcome combines the KRW move with the KRW/INR move between the day you remit and the day you convert back.